Content area

|
|

Radiofrekvensablation til behandling af levertumorer

Forfatter(e)
Tobias Bastian Ross Clemmesen1, Michael Patrick Achiam2, Christian Ross Pedersen2 & Peter Nørgaard Larsen2
1) Det Sundhedsvidenskabelige Fakultet, Københavns Universitet 2) Kirurgisk Gastroenterologisk Afdeling, Rigshospitalet

Ugeskr Læger 2019;181:V12180868
Reference: 
Ugeskr Læger 2019;181:V12180868

Tobias Bastian Ross Clemmesen, Michael Patrick Achiam2,
Christian Ross Pedersen & Peter Nørgaard Larsen:

Radiofrequency ablation for liver tumour treatment

Ugeskr Læger 2019;181:V12180868

This review presents the status of the use of radiofrequency ablation (RFA) of liver tumours. RFA is used in the treatment of hepatocellular carcinomas and colorectal liver metastases among others. The procedure can be done using percutaneous, laparoscopic and open surgical approaches. Many variables affect the outcome, and the comparison is difficult to conduct. Percutaneous RFA is less invasive, whereas better control of local recurrence and complete ablation may be achieved by open surgical RFA and laparoscopic RFA. However, open surgical RFA is associated with more complications and longer post-procedural hospitalisation than laparoscopic RFA and percutaneous RFA.

Du skal være logget ind for at læse denne artikel
Log ind

Right side